Fundraising Fox
Armatus Bio
6 employees on LinkedIn · 2 known investors
Find your way into Armatus Bio
Sign up to see every warm intro you have to Armatus Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Armatus Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
Investors · 2
Angel Physicians Fundlisted by Angel Physicians Fund
How we know: Angel Physicians Fund's portfolio page · Not right? Tell us
CincyTechlisted by CincyTechCincinnati · $500K – $750K
How we know: CincyTech's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
2 people who came through Armatus Bio went on to found or lead other companies.
Related companies · 8
AgenusAgenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL. It provides access to these investigational medicines for cancer patients through pathways such as clinical trials, Named Patient Programs, and compassionate-use programs across multiple countries.
Totus MedicinesTotus Medicines is a biopharmaceutical company developing small molecule drugs to address untreatable diseases by combining approaches in molecular design, structural biology, genetics, and cell biology. The company focuses on oncology and other therapeutic areas for patients with currently incurable conditions.
Arbutus Biopharma CorporationArbutus is a biotechnology company developing therapeutic assets and bringing them to market, with expertise spanning scientific, clinical, operational, and financial development. It focuses on drug development, partnerships, and licensing deals within the biopharma sector.
Talus BioTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Amicus TherapeuticsAmicus is a rare disease biotechnology company developing medicines for people with genetically defined conditions. It operates as a wholly owned subsidiary of BioMarin Pharmaceutical Inc.
Emmaus Life SciencesEmmaus Life Sciences is a pharmaceutical company that develops and commercializes Endari (prescription-grade L-glutamine oral powder), an FDA-approved treatment for sickle cell disease, and pursues additional indications such as diverticulosis. The company sells and seeks marketing authorization for its products in the United States and internationally, including the Middle East and North Africa region.
LatusLatus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.
Nautilus BiotechnologyNautilus develops proteomics technology to unlock the complexity of the human proteome for biomedical research and diagnostics. The company targets pharmaceutical, biotechnology, academic, clinical, and government sectors with advanced protein quantification and analysis platforms.
Companies working in the same space as Armatus Bio.
Frequently asked questions
- What does Armatus Bio do?
- Armatus Bio develops vectorized RNA interference therapeutics targeting genetic neurological and neuromuscular diseases.
- Who are Armatus Bio's investors?
- Armatus Bio's investors include Angel Physicians Fund, CincyTech.